China NT Pharma Group Company Limited (1011.HK) HKSE
0.55
+0(+0.00%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 454.39M |
| Enterprise Value | 764M |
| P/E Ratio | -12.32 |
| PEG Ratio | -0.23 |
| Price/Sales Ratio | 12.91 |
| Price/Book Ratio | -1.17 |
| Enterprise/Revenue | 25.73 |
| Enterprise/EBITDA | -50.46 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -1.08 |
| Operating Margin | -0.51 |
Management Effectiveness
| Return On Assets | -0.07 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 24.16M |
| Revenue/Share | 0.04 |
| Gross Profit | 9.61M |
| EBITDA | -12.32M |
| Net Income | -26.04M |
| Diluted EPS | -0.04 |
Balance Sheet
| Total Cash | 7.22M |
| Total Cash/Share | 0.01 |
| Total Debt | 316.83M |
| Total Debt/Equity | -1.16 |
| Current Ratio | 0.02 |
| Book Value Per Share | -0.41 |
Price History
| 52-Week Change | 30.95 |
| 52-Week High | 1.35 |
| 52-Week Low | 0.4 |
| Moving Average 50 Days | 0.66 |
| Moving Average 200 Days | 0.8 |
Statistics
| Average Volume | 245,680 |
| Shares Outstanding | 656.45M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | July 03, 2024 |
